Literature DB >> 24526875

The more, the better: modeling dravet syndrome with induced pluripotent stem cell-derived neurons.

Jennifer Kearney.   

Abstract

Year:  2014        PMID： 24526875      PMCID： PMC3913311          DOI： 10.5698/1535-7597-14.1.33

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  10 in total

1.  Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.

Authors:  Yu Liu; Luis F Lopez-Santiago; Yukun Yuan; Julie M Jones; Helen Zhang; Heather A O'Malley; Gustavo A Patino; Janelle E O'Brien; Raffaella Rusconi; Ajay Gupta; Robert C Thompson; Marvin R Natowicz; Miriam H Meisler; Lori L Isom; Jack M Parent
Journal:  Ann Neurol       Date:  2013-07-02       Impact factor: 10.422

2.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall
Journal:  Nat Neurosci       Date:  2006-08-20       Impact factor: 24.884

Review 3.  The core Dravet syndrome phenotype.

Authors:  Charlotte Dravet
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

Review 4.  Insights into pathophysiology and therapy from a mouse model of Dravet syndrome.

Authors:  John C Oakley; Franck Kalume; William A Catterall
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

Review 5.  The genetics of Dravet syndrome.

Authors:  Carla Marini; Ingrid E Scheffer; Rima Nabbout; Arvid Suls; Peter De Jonghe; Federico Zara; Renzo Guerrini
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.

Authors:  Ikuo Ogiwara; Hiroyuki Miyamoto; Noriyuki Morita; Nafiseh Atapour; Emi Mazaki; Ikuyo Inoue; Tamaki Takeuchi; Shigeyoshi Itohara; Yuchio Yanagawa; Kunihiko Obata; Teiichi Furuichi; Takao K Hensch; Kazuhiro Yamakawa
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

9.  Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis.

Authors:  Rickie Patani; Patrick A Lewis; Daniah Trabzuni; Clare A Puddifoot; David J A Wyllie; Robert Walker; Colin Smith; Giles E Hardingham; Michael Weale; John Hardy; Siddharthan Chandran; Mina Ryten
Journal:  J Neurochem       Date:  2012-07-10       Impact factor: 5.372

10.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.

Authors:  Scott C Baraban; Matthew T Dinday; Gabriela A Hortopan
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
  10 in total
  1 in total

1.  Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations.

Authors:  Min Jung Cho; Soon Sung Kwon; Ara Ko; Seung Tae Lee; Young Mock Lee; Heung Dong Kim; Hee Jung Chung; Se Hee Kim; Joon Soo Lee; Dae Sung Kim; Hoon Chul Kang
Journal:  J Clin Neurol       Date:  2017-10-31       Impact factor: 3.077
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.